Updates from AIM covered here includes news of the suspension of trading in the shares of a professional services group, which unfortunately looks worrying for shareholders. Elsewhere, a provider of alternative lending solutions has secured some alternative funding for itself, while one of our Bonkers Bargain opportunities impresses with its latest trading update. Read on for these and other stories.
Tristel encourages In its AGM statement, Tristel (AIM: TSTL), the manufacturer of infection prevention products, confirmed that its first half revenue is expected to exceed £17m, compared to £15m in the first half of last year. Gross margin is in line with expectations. The Group has made first sales in the United States and Canada and is preparing is preparing to submit their FDA application in March next year – progress in the key US market has been a long time coming. The current cash position is approximately £10m, which compares with £8.9m at the June 2022 year end. The…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login